These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1831578)

  • 1. Therapeutic advances in the prevention of hepatitis B: yeast-derived recombinant hepatitis B vaccines.
    Garrison MW; Baker DE
    DICP; 1991 Jun; 25(6):617-27. PubMed ID: 1831578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal hepatitis B vaccination.
    Rivey MP; Peterson J
    DICP; 1991 Jun; 25(6):628-34. PubMed ID: 1831579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped.
    Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S
    J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against hepatitis B in childhood as possible means of infection control].
    Giannone AM; Tozzi MC; Bruni L; Lelli A; Lops G; Angeloni U
    Minerva Pediatr; 1990 Nov; 42(11):461-3. PubMed ID: 2150541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.
    André FE
    Am J Med; 1989 Sep; 87(3A):14S-20S. PubMed ID: 2528292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(33):569-72. PubMed ID: 1830921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
    Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
    J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine.
    Just M; Berger R; Scheiermann N
    Vaccine; 1988 Oct; 6(5):401-2. PubMed ID: 2973694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity, reactogenicity and comparison of two doses of recombinant DNA yeast-derived hepatitis B vaccine in Ethiopian children.
    Tsega E; Tafesse B; Horton J; Nordenfelt E; Wolde-Hawariat G; Hansson BG; Lindberg J
    Trop Geogr Med; 1991; 43(1-2):220-7. PubMed ID: 1836290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccines.
    N Z Med J; 1988 Dec; 101(859):831. PubMed ID: 2974517
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine.
    Rogan PD; Duguid JK
    J Infect; 1991 Jan; 22(1):5-9. PubMed ID: 1825836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Centers for Disease Control. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    JAMA; 1991 Sep; 266(10):1338-9. PubMed ID: 1831865
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B vaccines: use in childhood.
    Moyes CD
    N Z Med J; 1988 Apr; 101(843):165-6. PubMed ID: 2965800
    [No Abstract]   [Full Text] [Related]  

  • 18. Scheduling of revaccination against hepatitis B virus.
    Coursaget P; Yvonnet B; Gilks WR; Wang CC; Day NE; Chiron JP; Diop-Mar I
    Lancet; 1991 May; 337(8751):1180-3. PubMed ID: 1673737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal hepatitis B vaccine.
    Lunn JA
    Lancet; 1989 Mar; 1(8638):625. PubMed ID: 2564156
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent developments in hepatitis: new virus, vaccine, and dosage recommendations.
    Cottone JA
    J Am Dent Assoc; 1990 May; 120(5):501-8. PubMed ID: 2139882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.